YENNY, Y. Aspirin for primary prevention of cardiovaascular events: what are the evidances?. Universa Medicina, [S. l.], v. 38, n. 3, p. 145–146, 2019. DOI: 10.18051/UnivMed.2019.v38.145-146. Disponível em: https://univmed.org/ejurnal/index.php/medicina/article/view/875. Acesso em: 26 apr. 2024.